These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22297461)

  • 1. Positron emission tomography imaging in neurological disorders.
    Politis M; Piccini P
    J Neurol; 2012 Sep; 259(9):1769-80. PubMed ID: 22297461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET in multiple sclerosis.
    Niccolini F; Su P; Politis M
    Clin Nucl Med; 2015 Jan; 40(1):e46-52. PubMed ID: 24561681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET molecular imaging in stem cell therapy for neurological diseases.
    Wang J; Tian M; Zhang H
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1926-38. PubMed ID: 21698414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography applications in clinical neurology.
    Singhal T
    Semin Neurol; 2012 Sep; 32(4):421-31. PubMed ID: 23361486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders.
    Virdee K; Cumming P; Caprioli D; Jupp B; Rominger A; Aigbirhio FI; Fryer TD; Riss PJ; Dalley JW
    Neurosci Biobehav Rev; 2012 Apr; 36(4):1188-216. PubMed ID: 22342372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography in neurological diseases.
    Kumar S; Rajshekher G; Prabhakar S
    Neurol India; 2005 Jun; 53(2):149-55. PubMed ID: 16010050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiopharmaceuticals in neurological and psychiatric disorders.
    Valotassiou V; Wozniak G; Sifakis N; Demakopoulos N; Georgoulias P
    Curr Clin Pharmacol; 2008 May; 3(2):99-107. PubMed ID: 18690884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of positron emission tomography (PET) in neurology.
    Tai YF; Piccini P
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):669-76. PubMed ID: 15090557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging of reactive astrocytes in neurological disorders.
    Liu Y; Jiang H; Qin X; Tian M; Zhang H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1275-1287. PubMed ID: 34873637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Positron emission tomography with FDG and newly developed tracers for the assessment of brain metabolism and synaptic function in neurological disorders].
    Momose T
    Brain Nerve; 2007 May; 59(5):495-501. PubMed ID: 17533975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments on PET radiotracers for TSPO and their applications in neuroimaging.
    Zhang L; Hu K; Shao T; Hou L; Zhang S; Ye W; Josephson L; Meyer JH; Zhang MR; Vasdev N; Wang J; Xu H; Wang L; Liang SH
    Acta Pharm Sin B; 2021 Feb; 11(2):373-393. PubMed ID: 33643818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography for brain research.
    Mishina M
    J Nippon Med Sch; 2008 Apr; 75(2):68-76. PubMed ID: 18475026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography and single-photon emission computed tomography in central nervous system drug development.
    Brooks DJ
    NeuroRx; 2005 Apr; 2(2):226-36. PubMed ID: 15897947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET imaging of neuroinflammation in neurological disorders.
    Kreisl WC; Kim MJ; Coughlin JM; Henter ID; Owen DR; Innis RB
    Lancet Neurol; 2020 Nov; 19(11):940-950. PubMed ID: 33098803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET Imaging in Huntington's Disease.
    Roussakis AA; Piccini P
    J Huntingtons Dis; 2015; 4(4):287-96. PubMed ID: 26683130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases.
    Cai Z; Li S; Matuskey D; Nabulsi N; Huang Y
    Neurosci Lett; 2019 Jan; 691():44-50. PubMed ID: 30075287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positron emission tomography in neuroscience. An integrative part of clinical diagnostic methods and experimental research].
    Schaller B
    Radiologe; 2005 Feb; 45(2):186, 188-96. PubMed ID: 15662519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography for modeling pathophysiological processes in vivo.
    Hendrikse NH; Luurtsema G; van der Veldt AA; Lubberink M
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):717-25. PubMed ID: 18729023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
    Kegeles LS; Mann JJ
    Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How far is arterial spin labeling MRI from a clinical reality? Insights from arterial spin labeling comparative studies in Alzheimer's disease and other neurological disorders.
    Zhang J
    J Magn Reson Imaging; 2016 May; 43(5):1020-45. PubMed ID: 26250802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.